Qureshi S A
Therapeutic Products Directorate, Health Canada, Banting Research Centre (A/L 2202C1), Ottawa, Canada, K1A 0L2.
Pharmeur Bio Sci Notes. 2009 Oct;2009(1):55-65.
Current practices of drug dissolution testing require that the experimental conditions, such as medium and its volume and apparatus and its associated stirrer rotation speed, be established for each test product to achieve certain 'expected' dissolution characteristics or results. In reality, however, the purpose of dissolution testing should be to determine potentially unknown dissolution results reflective of a test product based on its formulation and/or manufacturing attributes. For appropriate testing, in particular for comparative purposes, the experimental conditions must be the same or consistent from product to product i.e. product independent. This article describes a newly developed spindle, known as crescent-shaped, which can easily be installed in the vessel-based dissolution apparatuses (basket and paddle) to provide a product-independent dissolution testing approach for improved drug dissolution assessments. The new spindle provides an improved stirring and mixing environment, leading to better characterization of pharmaceutical products. The use of the crescent-shaped spindles offers additional significant advantages over the current practices, such as: (1) allows analyses using a single method, compared to hundreds as currently required, for both immediate and extended-released products having the same or different active ingredients; (2) provides improved dissolution characteristics of products by avoiding false slow release properties for fast release type products; (3) simplifies testing by avoiding the necessity of developing separate QC and bio-relevant dissolution methods; (4) provides a rugged testing environment free from common sensitivities, in particular to de-aeration and vibration effects. Considering that the new design provides significant advantages, the spindle may be considered for inclusion in the Ph. Eur., as an option, in the general chapter on dissolution testing.
当前的药物溶出度测试方法要求针对每种测试产品确定实验条件,如介质及其体积、仪器及其相关搅拌器转速,以实现特定的“预期”溶出特性或结果。然而,实际上,溶出度测试的目的应该是根据测试产品的配方和/或生产属性来确定反映该产品潜在未知的溶出结果。为了进行适当的测试,特别是出于比较目的,各产品之间的实验条件必须相同或一致,即与产品无关。本文介绍了一种新开发的称为月牙形的搅拌桨,它可以轻松安装在基于容器的溶出度测试仪器(篮法和桨法)中,以提供一种与产品无关的溶出度测试方法,用于改进药物溶出度评估。这种新的搅拌桨提供了更好的搅拌和混合环境,从而能更好地表征药品。与当前的方法相比,使用月牙形搅拌桨具有其他显著优势,例如:(1)对于具有相同或不同活性成分的速释和缓释产品,都允许使用单一方法进行分析,而目前需要数百种方法;(2)通过避免速释型产品出现假缓释特性,改善产品的溶出特性;(3)避免了开发单独的质量控制和生物相关溶出度方法的必要性,简化了测试;(4)提供了一个坚固的测试环境,不受常见敏感性因素影响,特别是脱气和振动影响。鉴于新设计具有显著优势,月牙形搅拌桨可作为一种选择,考虑纳入欧洲药典关于溶出度测试的通则章节中。